Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by David Bennett and Zoe Arvanitakis.
David Bennett
Connection Strength
11.745
Zoe Arvanitakis
  1. The Relation of Diabetes to Memory Function. Curr Neurol Neurosci Rep. 2020 11 05; 20(12):64.
    View in: PubMed
    Score: 0.731
  2. What Is Dementia? JAMA. 2019 11 05; 322(17):1728.
    View in: PubMed
    Score: 0.682
  3. Diagnosis and Management of Dementia: Review. JAMA. 2019 10 22; 322(16):1589-1599.
    View in: PubMed
    Score: 0.680
  4. Antiphospholipid Antibodies: Cognitive and Motor Decline, Neuroimaging and Neuropathology. Neuroepidemiology. 2019; 53(1-2):100-107.
    View in: PubMed
    Score: 0.659
  5. Memory complaints, dementia, and neuropathology in older blacks and whites. Ann Neurol. 2018 04; 83(4):718-729.
    View in: PubMed
    Score: 0.610
  6. Association of white matter hyperintensities and gray matter volume with cognition in older individuals without cognitive impairment. Brain Struct Funct. 2016 05; 221(4):2135-46.
    View in: PubMed
    Score: 0.496
  7. Relation of NSAIDs to incident AD, change in cognitive function, and AD pathology. Neurology. 2008 Jun 03; 70(23):2219-25.
    View in: PubMed
    Score: 0.309
  8. Statins, incident Alzheimer disease, change in cognitive function, and neuropathology. Neurology. 2008 May 06; 70(19 Pt 2):1795-802.
    View in: PubMed
    Score: 0.301
  9. Diabetes and parkinsonian signs in older persons. Alzheimer Dis Assoc Disord. 2007 Apr-Jun; 21(2):144-9.
    View in: PubMed
    Score: 0.285
  10. Diabetes is related to cerebral infarction but not to AD pathology in older persons. Neurology. 2006 Dec 12; 67(11):1960-5.
    View in: PubMed
    Score: 0.279
  11. Diabetes mellitus, dementia, and cognitive function in older persons. J Nutr Health Aging. 2006 Jul-Aug; 10(4):287-91.
    View in: PubMed
    Score: 0.270
  12. Diabetes and function in different cognitive systems in older individuals without dementia. Diabetes Care. 2006 Mar; 29(3):560-5.
    View in: PubMed
    Score: 0.264
  13. Diabetes mellitus and progression of rigidity and gait disturbance in older persons. Neurology. 2004 Sep 28; 63(6):996-1001.
    View in: PubMed
    Score: 0.239
  14. Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Arch Neurol. 2004 May; 61(5):661-6.
    View in: PubMed
    Score: 0.233
  15. Brain Insulin Signaling is Associated with Late-Life Cognitive Decline. Aging Dis. 2023 Nov 20.
    View in: PubMed
    Score: 0.226
  16. Metformin, age-related cognitive decline, and brain pathology. Neurobiol Aging. 2024 Jan; 133:99-106.
    View in: PubMed
    Score: 0.224
  17. Genome-Wide Mapping Implicates 5-Hydroxymethylcytosines in Diabetes Mellitus and Alzheimer's Disease. J Alzheimers Dis. 2023; 93(3):1135-1151.
    View in: PubMed
    Score: 0.212
  18. Derivation and validation of the Rapid Assessment of Dementia Risk (RADaR) for older adults. PLoS One. 2022; 17(3):e0265379.
    View in: PubMed
    Score: 0.201
  19. Brain insulin signaling and cerebrovascular disease in human postmortem brain. Acta Neuropathol Commun. 2021 04 15; 9(1):71.
    View in: PubMed
    Score: 0.188
  20. Brain Insulin Signaling, Alzheimer Disease Pathology, and Cognitive Function. Ann Neurol. 2020 09; 88(3):513-525.
    View in: PubMed
    Score: 0.179
  21. Association of Low Systolic Blood Pressure with Postmortem Amyloid-? and Tau. J Alzheimers Dis. 2020; 78(4):1755-1764.
    View in: PubMed
    Score: 0.172
  22. Insulin and adipokine signaling and their cross-regulation in postmortem human brain. Neurobiol Aging. 2019 12; 84:119-130.
    View in: PubMed
    Score: 0.168
  23. Brain IGFBP-5 modifies the relation of depressive symptoms to decline in cognition in older persons. J Affect Disord. 2019 05 01; 250:313-318.
    View in: PubMed
    Score: 0.163
  24. Sex differences in Alzheimer's disease and common neuropathologies of aging. Acta Neuropathol. 2018 12; 136(6):887-900.
    View in: PubMed
    Score: 0.159
  25. Late-life blood pressure association with cerebrovascular and Alzheimer disease pathology. Neurology. 2018 08 07; 91(6):e517-e525.
    View in: PubMed
    Score: 0.156
  26. Body Mass Index and Decline in Cognitive Function in Older Black and White Persons. J Gerontol A Biol Sci Med Sci. 2018 01 16; 73(2):198-203.
    View in: PubMed
    Score: 0.150
  27. Diabetes, Hemoglobin A1C, and Regional Alzheimer Disease and Infarct Pathology. Alzheimer Dis Assoc Disord. 2017 Jan-Mar; 31(1):41-47.
    View in: PubMed
    Score: 0.140
  28. White matter hyperintensities, incident mild cognitive impairment, and cognitive decline in old age. Ann Clin Transl Neurol. 2016 10; 3(10):791-800.
    View in: PubMed
    Score: 0.137
  29. Relation of cerebral vessel disease to Alzheimer's disease dementia and cognitive function in elderly people: a cross-sectional study. Lancet Neurol. 2016 08; 15(9):934-943.
    View in: PubMed
    Score: 0.135
  30. The Relationship of Cerebral Vessel Pathology to Brain Microinfarcts. Brain Pathol. 2017 01; 27(1):77-85.
    View in: PubMed
    Score: 0.133
  31. Diabetes is associated with cerebrovascular but not Alzheimer's disease neuropathology. Alzheimers Dement. 2016 08; 12(8):882-9.
    View in: PubMed
    Score: 0.131
  32. Relation of antiphospholipid antibodies to postmortem brain infarcts in older people. Circulation. 2015 Jan 13; 131(2):182-9.
    View in: PubMed
    Score: 0.120
  33. Gray-matter macrostructure in cognitively healthy older persons: associations with age and cognition. Brain Struct Funct. 2014 Nov; 219(6):2029-49.
    View in: PubMed
    Score: 0.111
  34. Faster cognitive decline in the years prior to MR imaging is associated with smaller hippocampal volumes in cognitively healthy older persons. Front Aging Neurosci. 2013; 5:21.
    View in: PubMed
    Score: 0.109
  35. Apolipoprotein E and change in episodic memory in blacks and whites. Neuroepidemiology. 2013; 40(3):211-9.
    View in: PubMed
    Score: 0.107
  36. Selected findings from the Religious Orders Study and Rush Memory and Aging Project. J Alzheimers Dis. 2013; 33 Suppl 1:S397-403.
    View in: PubMed
    Score: 0.106
  37. Antiphospholipid antibodies, brain infarcts, and cognitive and motor decline in aging (ABICMA): design of a community-based, longitudinal, clinical-pathological study. Neuroepidemiology. 2013; 40(2):73-84.
    View in: PubMed
    Score: 0.105
  38. Cognitive impairment, decline and fluctuations in older community-dwelling subjects with Lewy bodies. Brain. 2012 Oct; 135(Pt 10):3005-14.
    View in: PubMed
    Score: 0.104
  39. Overview and findings from the religious orders study. Curr Alzheimer Res. 2012 Jul; 9(6):628-45.
    View in: PubMed
    Score: 0.102
  40. Microinfarct pathology, dementia, and cognitive systems. Stroke. 2011 Mar; 42(3):722-7.
    View in: PubMed
    Score: 0.092
  41. Cerebral amyloid angiopathy pathology and cognitive domains in older persons. Ann Neurol. 2011 Feb; 69(2):320-7.
    View in: PubMed
    Score: 0.091
  42. Parkinsonian signs and incident falls in older persons without Parkinson's disease. J Am Geriatr Soc. 2010 Jan; 58(1):205-6.
    View in: PubMed
    Score: 0.086
  43. Diabetes and cognitive systems in older black and white persons. Alzheimer Dis Assoc Disord. 2010 Jan-Mar; 24(1):37-42.
    View in: PubMed
    Score: 0.086
  44. The neuropathology of probable Alzheimer disease and mild cognitive impairment. Ann Neurol. 2009 Aug; 66(2):200-8.
    View in: PubMed
    Score: 0.084
  45. Lower extremity motor function and disability in mild cognitive impairment. Exp Aging Res. 2007 Jul-Sep; 33(3):355-71.
    View in: PubMed
    Score: 0.072
  46. Subcortical infarcts, Alzheimer's disease pathology, and memory function in older persons. Ann Neurol. 2007 Jul; 62(1):59-66.
    View in: PubMed
    Score: 0.072
  47. Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology. 2007 Dec 11; 69(24):2197-204.
    View in: PubMed
    Score: 0.072
  48. Decision rules guiding the clinical diagnosis of Alzheimer's disease in two community-based cohort studies compared to standard practice in a clinic-based cohort study. Neuroepidemiology. 2006; 27(3):169-76.
    View in: PubMed
    Score: 0.069
  49. Blood pressure and lower limb function in older persons. J Gerontol A Biol Sci Med Sci. 2006 Aug; 61(8):839-43.
    View in: PubMed
    Score: 0.068
  50. Neuropathology of older persons without cognitive impairment from two community-based studies. Neurology. 2006 Jun 27; 66(12):1837-44.
    View in: PubMed
    Score: 0.068
  51. Parkinsonian signs in subjects with mild cognitive impairment. Neurology. 2005 Dec 27; 65(12):1901-6.
    View in: PubMed
    Score: 0.065
  52. Relation of blood pressure to risk of incident Alzheimer's disease and change in global cognitive function in older persons. Neuroepidemiology. 2006; 26(1):30-6.
    View in: PubMed
    Score: 0.064
  53. Glial heme oxygenase-1 expression in Alzheimer disease and mild cognitive impairment. Neurobiol Aging. 2006 Feb; 27(2):252-61.
    View in: PubMed
    Score: 0.062
  54. Profiles of lifestyle health behaviors and cognitive decline in older adults. Alzheimers Dement. 2023 Sep 07.
    View in: PubMed
    Score: 0.056
  55. The MIND diet, brain transcriptomic alterations, and dementia. medRxiv. 2023 Jun 13.
    View in: PubMed
    Score: 0.055
  56. Eicosanoid lipidome activation in post-mortem brain tissues of individuals with APOE4 and Alzheimer's dementia. Alzheimers Res Ther. 2022 10 11; 14(1):152.
    View in: PubMed
    Score: 0.052
  57. APOE e4 and Alzheimer's disease diagnosis associated differences in L-carnitine, GBB, TMAO, and acylcarnitines in blood and brain. Curr Res Transl Med. 2023 Jan-Mar; 71(1):103362.
    View in: PubMed
    Score: 0.052
  58. Calcium-dependent cytosolic phospholipase A2 activation is implicated in neuroinflammation and oxidative stress associated with ApoE4. Mol Neurodegener. 2022 06 15; 17(1):42.
    View in: PubMed
    Score: 0.051
  59. Retraction Note: Calcium-dependent cytosolic phospholipase A2 activation is implicated in neuroinflammation and oxidative stress associated with ApoE4. Mol Neurodegener. 2022 02 04; 17(1):14.
    View in: PubMed
    Score: 0.050
  60. Association of Hemoglobin A1C With TDP-43 Pathology in Community-Based Elders. Neurology. 2021 May 31; 96(22):e2694-e2703.
    View in: PubMed
    Score: 0.048
  61. Calcium-dependent cytosolic phospholipase A2 activation is implicated in neuroinflammation and oxidative stress associated with ApoE4. Mol Neurodegener. 2021 04 16; 16(1):26.
    View in: PubMed
    Score: 0.047
  62. Late-Life Vascular Risk Score in Association With Postmortem Cerebrovascular Disease Brain Pathologies. Stroke. 2021 06; 52(6):2060-2067.
    View in: PubMed
    Score: 0.047
  63. A? (Amyloid Beta) and Tau Tangle Pathology Modifies the Association Between Small Vessel Disease and Cortical Microinfarcts. Stroke. 2021 03; 52(3):1012-1021.
    View in: PubMed
    Score: 0.047
  64. Differences in the Associations Between Memory Complaints and Depressive Symptoms Among Black and White Older Adults. J Gerontol B Psychol Sci Soc Sci. 2020 03 09; 75(4):783-791.
    View in: PubMed
    Score: 0.044
  65. Association of Financial Literacy With Hospitalization in Community-dwelling Older Adults. Med Care. 2018 07; 56(7):596-602.
    View in: PubMed
    Score: 0.039
  66. Watershed microinfarct pathology and cognition in older persons. Neurobiol Aging. 2018 10; 70:10-17.
    View in: PubMed
    Score: 0.039
  67. Purpose in Life and Hospitalization for Ambulatory Care-Sensitive Conditions in Old Age. Am J Geriatr Psychiatry. 2018 03; 26(3):364-374.
    View in: PubMed
    Score: 0.036
  68. Association of Cancer History with Alzheimer's Disease Dementia and Neuropathology. J Alzheimers Dis. 2017; 56(2):699-706.
    View in: PubMed
    Score: 0.035
  69. Cerebrovascular and microglial states are not altered by functional neuroinflammatory gene variant. J Cereb Blood Flow Metab. 2016 Apr; 36(4):819-30.
    View in: PubMed
    Score: 0.033
  70. APOE and cerebral amyloid angiopathy in community-dwelling older persons. Neurobiol Aging. 2015 Nov; 36(11):2946-2953.
    View in: PubMed
    Score: 0.032
  71. Mixed pathology is more likely in black than white decedents with Alzheimer dementia. Neurology. 2015 Aug 11; 85(6):528-34.
    View in: PubMed
    Score: 0.032
  72. Physical activity, motor function, and white matter hyperintensity burden in healthy older adults. Neurology. 2015 Mar 31; 84(13):1294-300.
    View in: PubMed
    Score: 0.031
  73. Astroglial heme oxygenase-1 and the origin of corpora amylacea in aging and degenerating neural tissues. Exp Neurol. 2014 Apr; 254:78-89.
    View in: PubMed
    Score: 0.029
  74. Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J Clin Invest. 2012 Apr; 122(4):1316-38.
    View in: PubMed
    Score: 0.025
  75. Brain sterol dysregulation in sporadic AD and MCI: relationship to heme oxygenase-1. J Neurochem. 2009 Aug; 110(4):1241-53.
    View in: PubMed
    Score: 0.021
  76. Brain erythropoietin receptor expression in Alzheimer disease and mild cognitive impairment. J Neuropathol Exp Neurol. 2007 May; 66(5):389-98.
    View in: PubMed
    Score: 0.018
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.